Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Synchronous aldosterone- and cortisol-producing adrenocortical adenomas diagnosed using CYP11B immunohistochemistry.

Stenman A, Shabo I, Ramström A, Zedenius J, Juhlin CC.

SAGE Open Med Case Rep. 2019 Oct 18;7:2050313X19883770. doi: 10.1177/2050313X19883770. eCollection 2019.

2.

Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease.

Hysek M, Paulsson JO, Jatta K, Shabo I, Stenman A, Höög A, Larsson C, Zedenius J, Juhlin CC.

Cancers (Basel). 2019 Sep 26;11(10). pii: E1443. doi: 10.3390/cancers11101443.

3.

Differences in intra-tumoral macrophage infiltration and radiotherapy response among intrinsic subtypes in pT1-T2 breast cancers treated with breast-conserving surgery.

Garvin S, Vikhe Patil E, Arnesson LG, Oda H, Hedayati E, Lindström A, Shabo I.

Virchows Arch. 2019 Aug;475(2):151-162. doi: 10.1007/s00428-019-02563-3. Epub 2019 Mar 26.

4.

The expression profile of p14, p53 and p21 in tumour cells is associated with disease-specific survival and the outcome of postoperative chemotherapy treatment in muscle-invasive bladder cancer.

Aljabery F, Shabo I, Gimm O, Jahnson S, Olsson H.

Urol Oncol. 2018 Dec;36(12):530.e7-530.e18. doi: 10.1016/j.urolonc.2018.05.025. Epub 2018 Oct 24.

PMID:
30539751
5.

Clear Cell Variant of a Follicular Thyroid Tumor With Uncertain Malignant Potential: A Case Report.

Juhlin CC, Bränström R, Shabo I, Höög A.

Int J Surg Pathol. 2019 May;27(3):290-293. doi: 10.1177/1066896918809490. Epub 2018 Oct 29.

PMID:
30370813
6.

TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routine.

Hysek M, Paulsson JO, Wang N, Jatta K, Lindh C, Fuentes-Martinez N, Shabo I, Zedenius J, Juhlin CC.

Virchows Arch. 2018 Nov;473(5):639-643. doi: 10.1007/s00428-018-2386-1. Epub 2018 Jun 2.

PMID:
29860621
7.

Tumor cell expression of CD163 is associated to postoperative radiotherapy and poor prognosis in patients with breast cancer treated with breast-conserving surgery.

Garvin S, Oda H, Arnesson LG, Lindström A, Shabo I.

J Cancer Res Clin Oncol. 2018 Jul;144(7):1253-1263. doi: 10.1007/s00432-018-2646-0. Epub 2018 May 3.

8.

TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours.

Paulsson JO, Mu N, Shabo I, Wang N, Zedenius J, Larsson C, Juhlin CC.

Endocr Relat Cancer. 2018 Jul;25(7):723-733. doi: 10.1530/ERC-18-0050. Epub 2018 Apr 24.

PMID:
29692346
9.

Somatostatin Receptor Expression in Renal Cell Carcinoma-A New Front in the Diagnostics and Treatment of Renal Cell Carcinoma.

Höög A, Kjellman M, Mattsson P, Juhlin CC, Shabo I.

Clin Genitourin Cancer. 2018 Jun;16(3):e517-e520. doi: 10.1016/j.clgc.2018.03.011. Epub 2018 Mar 27. No abstract available.

PMID:
29656940
10.

M2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancer.

Aljabery F, Olsson H, Gimm O, Jahnson S, Shabo I.

Urol Oncol. 2018 Apr;36(4):159.e19-159.e26. doi: 10.1016/j.urolonc.2017.11.020. Epub 2017 Dec 26.

PMID:
29288002
11.

Fusion between M2-macrophages and cancer cells results in a subpopulation of radioresistant cells with enhanced DNA-repair capacity.

Lindström A, Midtbö K, Arnesson LG, Garvin S, Shabo I.

Oncotarget. 2017 May 18;8(31):51370-51386. doi: 10.18632/oncotarget.17986. eCollection 2017 Aug 1.

12.

Radio-guided sentinel lymph node detection and lymph node mapping in invasive urinary bladder cancer: a prospective clinical study.

Aljabery F, Shabo I, Olsson H, Gimm O, Jahnson S.

BJU Int. 2017 Sep;120(3):329-336. doi: 10.1111/bju.13700. Epub 2016 Dec 4.

13.

Macrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction.

Shabo I, Midtbö K, Andersson H, Åkerlund E, Olsson H, Wegman P, Gunnarsson C, Lindström A.

BMC Cancer. 2015 Nov 20;15:922. doi: 10.1186/s12885-015-1935-0.

14.

PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer.

Aljabery F, Lindblom G, Skoog S, Shabo I, Olsson H, Rosell J, Jahnson S.

BMC Urol. 2015 Aug 21;15:87. doi: 10.1186/s12894-015-0080-z.

15.

Macrophage Infiltration in Tumor Stroma is Related to Tumor Cell Expression of CD163 in Colorectal Cancer.

Shabo I, Olsson H, Elkarim R, Sun XF, Svanvik J.

Cancer Microenviron. 2014 Aug;7(1-2):61-9. doi: 10.1007/s12307-014-0145-7. Epub 2014 Apr 28.

16.

Review and rhyme--of birth of cancers and selfish epigenomes.

Svanvik J, Shabo I.

Med Hypotheses. 2014 May;82(5):639-40. doi: 10.1016/j.mehy.2014.01.035. Epub 2014 Feb 10. No abstract available.

PMID:
24612784
17.

Breast cancer expression of DAP12 is associated with skeletal and liver metastases and poor survival.

Shabo I, Olsson H, Stål O, Svanvik J.

Clin Breast Cancer. 2013 Oct;13(5):371-7. doi: 10.1016/j.clbc.2013.05.003. Epub 2013 Jun 27.

PMID:
23810293
18.

Expression of macrophage antigens by tumor cells.

Shabo I, Svanvik J.

Adv Exp Med Biol. 2011;714:141-50. doi: 10.1007/978-94-007-0782-5_7. Review.

PMID:
21506012
19.

Postoperative intra-arterial methylene blue injection of colorectal cancer specimens increases the number of lymph nodes recovered.

Törnroos A, Shabo I, Druvefors B, Arbman G, Olsson H.

Histopathology. 2011 Feb;58(3):408-13. doi: 10.1111/j.1365-2559.2011.03755.x. Epub 2011 Feb 16.

PMID:
21323959
20.

Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time.

Shabo I, Olsson H, Sun XF, Svanvik J.

Int J Cancer. 2009 Oct 15;125(8):1826-31. doi: 10.1002/ijc.24506.

Supplemental Content

Loading ...
Support Center